Fungi Bioactive Metabolites

Part I: Bioactive Compounds from Endophytic Fungi.- Chapter 1. Recent Advances in Pharmaceutically Important Compounds from Endophytic Fungi.- Chapter 2. Pharmaceutically Important Compound Produced by Endophytic Fungi Having Anti-Infective Activity.- Chapter 3. Fungal Endophytes: An Accessible Natural Repository for Discovery of Bioactive Compounds.- Part II: Endolichenic Fungi: A Source of New Chemical Entities.- Chapter 4. Endolichenic Fungi as a Source of Pharmaceutically Active Compounds.- Chapter 5. Endolichenic Fungi, an Emerging Source of Bioactive Compounds: A Pharmaceutical Perspective.- Part III: Marine Fungi as a Source of Medicinal Compounds.- Chapter 6. Antibiofilm Metabolites from Sponge-derived Aspergillus, Penicillium, and Fusarium for the Antibiotic Pipeline.- Chapter 7. Marine Fungi as a Bioresource of Medicinal Entities.- Chapter 8. Natural Bioactive Products from Marine Fungi against Bacterial Infection. Part IV: Fungi as a Bioresource of Pharmacologically Active Agents.- Chapter 9. Penicillium: A Treasure-Trove for Antimycobacterial and Antioxidant Metabolites.- Chapter 10. Metabolites from Fungi: a Promising Source of Lead Compounds against Cancer.- Chapter 11. Edible Mushrooms Substances as Natural Prevention in Autoimmunological Diseases.- Chapter 12. New Antifungal Drugs: Discovery and Therapeutic Potential.- Chapter 13. Fungal Enzyme Inhibitors: Potent Repository of Lead Compounds to Curb Cancer.- Chapter 14. Bioactive Metabolites from Fungi with Anti-Inflammatory and Anti-Thrombotic Properties; Current Status and Future Perspectives for Drug Development.- Chapter 15. Progress in the Development of Fungal Metabolites as New Drugs for Human Mycoses.- Part V: Fungi from Extremophilic Environment/Unique Ecosystems.- Chapter 16. Uncovering the Desert Fungal Enigma: An Attractive Resource for Biopharmaceuticals.- Chapter 17. Bioactive Metabolites Produced by Fungi Present inAntarctic, Arctic and Alpine Ecosystems.- Part VI: Novel Strategies to Screen or Enhance Secondary Metabolite Production.- Chapter 18. Enhancing Chemical Diversity of Fungal Secondary Metabolite by OSMAC Strategy.- Chapter 19. Epigenetic Regulation of Fungal Secondary Metabolites for the Enhancement of Therapeutically Active Compounds.- Chapter 20. Strategies for Enhancing the Production of Echinocandin.- Part VII: Other by Products of Fungal Metabolism with Medicinal Applications.- Chapter 21. Fungal Pigments: Applications and Their Medicinal Potential.- Chapter 22. A Brief Insight into Peptide and Non-Peptide Drugs of Fungal Origin.- Chapter 23. Kojic Acid from Aspergillus wentii: A Journey from Isolation to Application.- Part VIII: Bioinformatics and Fungal Biotransformations in Pharmaceutical Drug Development.- Chapter 24. How Does Bioinformatics Play a Role in Fungal Drug Discovery?.- Chapter 25. Fungal Biotransformation of Steroids: History, Current Status, and Future Prospects.

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Pesquisa médica
• Biotecnologia
• Biologia molecular
• Ciência ecológica, a biosfera
• Biologia Celular (citologia)

fungal diversity;marine fungi;Antibacterial;Metabolic disorders;fungal bioactives;pathogenic fungi